Pierre Osteil
Children's Medical Research Institute
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Pierre Osteil.
Nature Communications | 2015
Hongwei Chen; Irene Aksoy; Fabrice Gonnot; Pierre Osteil; Maxime Aubry; Claire Hamela; Cloé Rognard; Arnaud Hochard; Sophie Voisin; Emeline Fontaine; Magali Mure; Marielle Afanassieff; Elouan Cleroux; Sylvain Guibert; Jiaxuan Chen; Céline Vallot; Hervé Acloque; Clémence Genthon; Cécile Donnadieu; John De Vos; Damien Sanlaville; Jean François Guérin; Michael Weber; Lawrence W. Stanton; Claire Rougeulle; Bertrand Pain; Pierre-Yves Bourillot; Pierre Savatier
Leukemia inhibitory factor (LIF)/STAT3 signalling is a hallmark of naive pluripotency in rodent pluripotent stem cells (PSCs), whereas fibroblast growth factor (FGF)-2 and activin/nodal signalling is required to sustain self-renewal of human PSCs in a condition referred to as the primed state. It is unknown why LIF/STAT3 signalling alone fails to sustain pluripotency in human PSCs. Here we show that the forced expression of the hormone-dependent STAT3-ER (ER, ligand-binding domain of the human oestrogen receptor) in combination with 2i/LIF and tamoxifen allows human PSCs to escape from the primed state and enter a state characterized by the activation of STAT3 target genes and long-term self-renewal in FGF2- and feeder-free conditions. These cells acquire growth properties, a gene expression profile and an epigenetic landscape closer to those described in mouse naive PSCs. Together, these results show that temporarily increasing STAT3 activity is sufficient to reprogramme human PSCs to naive-like pluripotent cells.
Biology Open | 2013
Pierre Osteil; Yann Tapponnier; Suzy Markossian; Barbara Schmaltz-Panneau; Luc Jouneau; Cédric Cabau; Thierry Joly; Thierry Blachère; Elen Gócza; Agnieszka Bernat; M. Yerle; Hervé Acloque; Sullivan Hidot; Zsuzsanna Bösze; Véronique Duranthon; Pierre Savatier; Marielle Afanassieff
Summary Not much is known about the molecular and functional features of pluripotent stem cells (PSCs) in rabbits. To address this, we derived and characterized 2 types of rabbit PSCs from the same breed of New Zealand White rabbits: 4 lines of embryonic stem cells (rbESCs), and 3 lines of induced PSCs (rbiPSCs) that were obtained by reprogramming adult skin fibroblasts. All cell lines required fibroblast growth factor 2 for their growth and proliferation. All rbESC lines showed molecular and functional properties typically associated with primed pluripotency. The cell cycle of rbESCs had a prolonged G1 phase and a DNA damage checkpoint before entry into the S phase, which are the 2 features typically associated with the somatic cell cycle. In contrast, the rbiPSC lines exhibited some characteristics of naïve pluripotency, including resistance to single-cell dissociation by trypsin, robust activity of the distal enhancer of the mouse Oct4 gene, and expression of naïve pluripotency-specific genes, as defined in rodents. According to gene expression profiles, rbiPSCs were closer to the rabbit inner cell mass (ICM) than rbESCs. Furthermore, rbiPSCs were capable of colonizing the ICM after aggregation with morulas. Therefore, we propose that rbiPSCs self-renew in an intermediate state between naïve and primed pluripotency, which represents a key step toward the generation of bona fide naïve PSC lines in rabbits.
Animal Reproduction Science | 2014
Barbara Schmaltz-Panneau; Luc Jouneau; Pierre Osteil; Yann Tapponnier; Marielle Afanassieff; Marco Moroldo; Alice Jouneau; Nathalie Daniel; Catherine Archilla; Pierre Savatier; Véronique Duranthon
Pluripotency refers to the ability for a single cell to differentiate into the three embryonic germ layers. In mice, two types of pluripotent stem cells with different features have been obtained in vitro. Naive pluripotent stem cells are derived from the inner cell mass (ICM) of early blastocyst (ESCs) or reprogrammed from somatic cells (iPSCs), while primed pluripotent stem cells are derived from late epiblast (EpiSCs). Cells in a primed pluripotency state are more prone to differentiation and only naive pluripotent stem cells form germline chimera after injection into a blastocyst. Despite numerous attempts, capturing pluripotency in domestic mammalian species has been largely unsuccessful and only primed pluripotent stem cells have been obtained even starting from early blastocyst or reprogramming somatic cells. This raises two questions: whether inner cell mass and epiblast are in naive or primed pluripotency state and what are the transcriptome features of ESCs and iPSCs in these species. To address these questions we compared rabbit ICM, epiblast, ESCs and iPSCs transcriptomes. Our results show that: (i) molecular signature of naïve and primed pluripotency may differ between mice and rabbit embryos; (ii) Genes involved in G1/S transition of the cell-cycle, actin cytoskeleton signaling, development and differentiation pathways are upregulated in ESCs and iPSCs; (iii) ICM and epiblast upregulate pluripotency associated genes and display specific metabolic features. These results denote an advanced primed state of pluripotency for rabbit ESCs and iPSCs and evidence specific functions for ICM and epiblast that are not shared by ESCs and iPSCs.
Stem Cell Research | 2017
Pierre Savatier; Pierre Osteil; Patrick P.L. Tam
The diverse cell states and in vitro conditions for the derivation and maintenance of the mammalian embryo-derived pluripotent stem cells raise the questions of whether there are multiple states of pluripotency of the stem cells of each species, and if there are innate species-specific variations in the pluripotency state. We will address these questions by taking a snapshot of our knowledge of the properties of the pluripotent stem cells, focusing on the maintenance of pluripotency and inter-conversion of the different types of pluripotent stem cells from rodents, lagomorphs and primates. We conceptualize pluripotent stem cells acquiring a series of cellular states represented as terraces on a slope of descending gradient of pluripotency. We propose that reprogramming pluripotent stem cells from a primed to a naive state is akin to moving upstream over a steep cliff to a higher terrace.
Differentiation | 2016
Pierre Osteil; Joshua B. Studdert; Emilie Wilkie; Nicolas Fossat; Patrick P.L. Tam
Conventionally, mouse epiblast stem cells (EpiSCs) are derived directly from the epiblast or ectoderm germ layer of the post-implantation embryo. Self-renewing and multipotent EpiSC-like stem cells can also be derived by the conversion of embryonic stem cells (ESCs) via the provision of culture conditions that enable the maintenance of the EpiSCs. Here, we outline an experimental procedure for deriving EpiSCs from post-implantation chimeric embryos that are generated using genome-edited ESCs. This strategy enables the production of EpiSCs where (i) no genetically modified animals or ESCs are available, (ii) the impact of the genetic modification on post-implantation development, which may influence the property of the EpiSCs, is requisite knowledge for using the EpiSC for a specific investigation, and (iii) multiple editing of the genome is desirable to modify the biological attributes of the EpiSCs for studying, for example, the gene network activity on the trajectory of lineage differentiation and tissue morphogenesis.
bioRxiv | 2018
Clayton E. Friedman; Quan Nguyen; Samuel W. Lukowski; Abbigail Helfer; Han Chiu; Holly K. Voges; Shengbao Suo; Jing-Dong Han; Pierre Osteil; Guangdun Peng; Naihe Jing; Greg Ballie; Anne Senabouth; Angelika N. Christ; Timothy J. C. Bruxner; Charles E. Murry; Emily S. W. Wong; Jun Ding; Yuliang Wang; James E. Hudson; Ziv Bar-Joseph; Patrick P.L. Tam; Joseph E. Powell; Nathan J. Palpant
Differentiation into diverse cell lineages requires the orchestration of gene regulatory networks guiding diverse cell fate choices. Utilizing human pluripotent stem cells, we measured expression dynamics of 17,718 genes from 43,168 cells across five-time points over a thirty-day time-course of in vitro cardiac- directed differentiation. Unsupervised clustering and lineage prediction algorithms were used to map fate choices and transcriptional networks underlying cardiac differentiation. We leveraged this resource to identify strategies for controlling in vitro differentiation as it occurs in vivo. HOPX, a non-DNA binding homeodomain protein essential for heart development in vivo was identified as dysregulated in vitro derived cardiomyocytes. Utilizing genetic gain and loss of function approaches, we dissect the transcriptional complexity of the HOPX locus and identify the requirement of hypertrophic signaling for HOPX transcription in hPSC-derived cardiomyocytes. This work provides a single cell dissection of the transcriptional landscape of cardiac differentiation for broad applications of stem cells in cardiovascular biology.Differentiation into diverse cell lineages requires orchestration of gene regulatory networks guiding cell fate choices. Here, we present the dissection of cellular composition and gene networks from transcriptomic data of 43,168 cells across five discrete time points during cardiac-directed differentiation. We utilize unsupervised clustering and implement a lineage trajectory prediction algorithm that integrates transcription factor networks to predict cell fate progression of 15 subpopulations that correlate with germ layer and cardiovascular differentiation in vivo. These data reveal transcriptional networks underlying lineage derivation of mesoderm, definitive endoderm, vascular endothelium, cardiac precursors, and definitive cell types that comprise cardiomyocytes and a previously unrecognized cardiac outflow tract population. Single cell analysis of genetic regulators governing cardiac fate diversification identified the non-DNA binding homeodomain protein, HOPX, as functionally necessary for endothelial specification. Our findings further implicate dysregulation of HOPX during in vitro cardiac-directed differentiation underlying the molecular and physiological immaturity of stem cell-derived cardiomyocytes.
Stem cell reports | 2018
Chang Liu; Ran Wang; Zhisong He; Pierre Osteil; Emilie Wilkie; Xianfa Yang; Jun Chen; Guizhong Cui; Wenke Guo; Yingying Chen; Guangdun Peng; Patrick P.L. Tam; Naihe Jing
Summary The molecular mechanism underpinning the specification of the ectoderm, a transient germ-layer tissue, during mouse gastrulation was examined here in a stem cell-based model. We captured a self-renewing cell population with enhanced ectoderm potency from mouse epiblast stem cells (EpiSCs) by suppressing Nodal signaling activity. The transcriptome of the Nodal-inhibited EpiSCs resembles that of the anterior epiblast of embryonic day (E)7.0 and E7.5 mouse embryo, which is accompanied by chromatin modifications that reflect the priming of ectoderm lineage-related genes for expression. Nodal-inhibited EpiSCs show enhanced ectoderm differentiation in vitro and contribute to the neuroectoderm and the surface ectoderm in postimplantation chimeras but lose the propensity for mesendoderm differentiation in vitro and in chimeras. Our findings show that specification of the ectoderm progenitors is enhanced by the repression of Nodal signaling activity, and the ectoderm-like stem cells provide an experimental model to investigate the molecular characters of the epiblast-derived ectoderm.
Mechanisms of Development | 2017
Pierre Osteil; Emilie Wilkie; Renée Rawson; Joshua B. Studdert; Patrick P.L. Tam
This study aims to elucidate the molecular activity that influences lineage propensity in the early mouse embryo. To this aim, we used the embryo-derived epiblast stem cells (EpiSCs), which are developmentally similar to the epiblast of the gastrulating mouse embryo. WNT signalling activity can be modulated during the derivation and maintenance of the EpiSCs through blocking the release of WNT ligands by the chemical inhibitor IWP2. The blocking of WNT signalling activity leads to a bias of differentiation of the EpiSCs towards ectoderm derivatives, in contrast to the propensity of mesendoderm differentiation of classical EpiSCs. Analysis of the gene expression profiles revealed differences in the transcriptome between both EpiSCs. In the gastrulating embryo, the allocation of the epiblast cells to the mesendoderm lineage is accompanied by the expression of genes including Mixl1, a homeodomain transcription factor. Mixl1 is down regulated in the EpiSCs when WNT activity is inhibited, consistent with the bias of these EpiSCs toward ectodermal cells. This shift in cell differentiation trajectory implicates the plasticity of cell fates of EpiSC derived in WNT-free condition and that the lineage propensity can be re-set by changes in WNT activity. Interestingly, the mesendoderm propensity of the EpiSCs is correlated with the expediency and magnitude of activation of Mixl1. Further evidences gleaned from EpiSCs studies, place Mixl1 as a major regulator transcription factor for EMT – MET process during gastrulation in the mouse embryo. Given that Mixl1 activity may be regulated by WNT signalling, this raise the possibility that the activity of WNT-Mixl1 cascade is key to mesendoderm differentiation of the EpiSCs. Modulation of WNT activity and Mixl1 therefore have a convergent function in controlling the differentiation of the progenitor of germ layer tissues.
Methods of Molecular Biology | 2015
Marielle Afanassieff; Pierre Osteil; Pierre Savatier
Here we have described a procedure to generate embryonic stem cell (ESC) lines from rabbit preimplantation blastocysts. We have also provided detailed procedures to characterize the resulting ESC lines, such as the analysis of pluripotency marker expression by reverse transcription quantitative polymerase chain reaction, immunolabeling, and fluorescence-associated cell sorting; evaluation of pluripotency by teratoma production; and assessment of genetic stability by karyotyping.
bioRxiv | 2018
Clayton E. Friedman; Quan Nguyen; Samuel W. Lukowski; Abbigail Helfer; Han Sheng Chiu; Holly K. Voges; Shengbao Suo Suo; Jing-Dong J. Han; Pierre Osteil; Guangdun Peng; Naihe Jing; Greg J. Baillie; Anne Senabouth; Angelika N. Christ; Timothy J. C. Bruxner; Charles E. Murry; Emily S. W. Wong; Jun Ding; Yuliang Wang; James E. Hudson; Ziv Bar-Joseph; Patrick P.L. Tam; Joseph E. Powell; Nathan J. Palpant